Skip to content
★ Sign in to follow
JG

Johan Giléus

InDex Pharmaceuticals Holding AB
Total declarations
9
Company
1
▲ Purchases (5 ops.)
€32k
▼ Sales (0 ops.)
—

Latest filing published 14 Jul 2023 for InDex Pharmaceuticals Holding AB.

Filing timeline

BuySale
Johan Giléus

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Johan Giléus: trading record in brief

Johan Giléus is a declared insider of InDex Pharmaceuticals Holding AB, with filings sourced from Finansinspektionen. Between 20 April 2017 and 12 July 2023, the trades on record add up to 9 filings.

Purchases make up the whole of the open-market record (5 purchases, €32k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants. In 2023 alone, the filings show 1 purchase and no sales.

The median purchase comes to €7,005. On 2 out of 5 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 14 July 2023: a share grant, in InDex Pharmaceuticals Holding AB. The latest purchase dates back some time: it was published 1,353 days ago, on 24 February 2023. Most trades are made public on the day they happen. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Johan Giléus

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations